Reuterin in the healthy gut microbiome suppresses colorectal cancer growth through altering redox balance.
暂无分享,去创建一个
Peter K. Todd | Nupur K. Das | S. Gygi | E. Fearon | J. Mancias | C. Lyssiotis | Y. Shah | Miljan Kuljanin | P. Todd | Ryan J. Rebernick | Shannon L. Miller | Sumeet Solanki | J. Goyert | Hannah N. Bell | Rashi Singhal | A. Andren | Wesley Huang | S. Kerk
[1] K. Obama,et al. Gut bacteria identified in colorectal cancer patients promote tumourigenesis via butyrate secretion , 2021, Nature Communications.
[2] E. Elinav,et al. Microbiome and cancer. , 2021, Cancer cell.
[3] J. Xia,et al. MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights , 2021, Nucleic Acids Res..
[4] Nupur K. Das,et al. HIF-2α activation potentiates oxidative cell death in colorectal cancers by increasing cellular iron. , 2021, The Journal of clinical investigation.
[5] Seung-Hwan Lee,et al. Targeting SLC1A5 and SLC3A2/SLC7A5 as a Potential Strategy to Strengthen Anti-Tumor Immunity in the Tumor Microenvironment , 2021, Frontiers in Immunology.
[6] F. Taieb,et al. A Toxic Friend: Genotoxic and Mutagenic Activity of the Probiotic Strain Escherichia coli Nissle 1917 , 2021, bioRxiv.
[7] Devin K. Schweppe,et al. Reimagining high-throughput profiling of reactive cysteines for cell-based screening of large electrophile libraries , 2021, Nature Biotechnology.
[8] J. Walter,et al. A Phylogenetic View on the Role of Glycerol for Growth Enhancement and Reuterin Formation in Limosilactobacillus reuteri , 2020, Frontiers in Microbiology.
[9] T. Moss,et al. The chemotherapeutic agent CX-5461 irreversibly blocks RNA polymerase I initiation and promoter release to cause nucleolar disruption, DNA damage and cell inviability , 2020, NAR cancer.
[10] S. Wedge,et al. Therapeutic Strategies Toward Lactate Dehydrogenase Within the Tumor Microenvironment of Pancreatic Cancer. , 2020, Pancreas.
[11] Philippe P Roux,et al. RIOK2 phosphorylation by RSK promotes synthesis of the human small ribosomal subunit , 2020, bioRxiv.
[12] A. Chinnaiyan,et al. Cancer SLC43A2 alters T cell methionine metabolism and histone methylation , 2020, Nature.
[13] M. Jarek,et al. Crypt residing bacteria and proximal colonic carcinogenesis in a mouse model of Lynch syndrome , 2020, International journal of cancer.
[14] I. Harris,et al. The Complex Interplay between Antioxidants and ROS in Cancer. , 2020, Trends in cell biology.
[15] A. Need,et al. Mutational signature in colorectal cancer caused by genotoxic pks+E. coli , 2020, Nature.
[16] C. Lacroix,et al. Reuterin Demonstrates Potent Antimicrobial Activity Against a Broad Panel of Human and Poultry Meat Campylobacter spp. Isolates , 2020, Microorganisms.
[17] Jun Sun,et al. Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer. , 2020, Gastroenterology.
[18] D. Graham,et al. Twice‐a‐day PPI, tetracycline, metronidazole quadruple therapy with Pylera® or Lactobacillus reuteri for treatment naïve or for retreatment of Helicobacter pylori. Two randomized pilot studies , 2019, Helicobacter.
[19] Nupur K. Das,et al. Microbial Metabolite Signaling Is Required for Systemic Iron Homeostasis. , 2019, Cell metabolism.
[20] M. Clapper,et al. Gut Microbiota Influences Experimental Outcomes in Mouse Models of Colorectal Cancer , 2019, Genes.
[21] Y. Jeong,et al. Synergistic effect of buthionine sulfoximine on the chlorin e6-based photodynamic treatment of cancer cells , 2019, Archives of Pharmacal Research.
[22] Tomoyoshi Soga,et al. Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer , 2019, Nature Medicine.
[23] Xu Ren,et al. Negative binomial additive model for RNA-Seq data analysis , 2019, bioRxiv.
[24] J. Colacino,et al. Neutrophils Restrict Tumor-Associated Microbiota to Reduce Growth and Invasion of Colon Tumors in Mice. , 2019, Gastroenterology.
[25] Paul Theodor Pyl,et al. Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer , 2019, Nature Medicine.
[26] Julia L. Drewes,et al. Human colon mucosal biofilms from healthy or colon cancer hosts are carcinogenic , 2019, The Journal of clinical investigation.
[27] Nupur K. Das,et al. Intestinal non-canonical NFκB signaling shapes the local and systemic immune response , 2019, Nature Communications.
[28] G. Khan,et al. Colorectal Cancer and Nutrition , 2019, Nutrients.
[29] Mark Gerstein,et al. GENCODE reference annotation for the human and mouse genomes , 2018, Nucleic Acids Res..
[30] K. Karbstein,et al. Ribosome biogenesis factor Ltv1 chaperones the assembly of the small subunit head , 2018, The Journal of cell biology.
[31] J. Lapek,et al. Dysregulated Microbial Fermentation of Soluble Fiber Induces Cholestatic Liver Cancer , 2018, Cell.
[32] Robert E. W. Hancock,et al. MetaBridge: enabling network-based integrative analysis via direct protein interactors of metabolites , 2018, Bioinform..
[33] L. Diaz,et al. KEYNOTE-164: Pembrolizumab for patients with advanced microsatellite instability high (MSI-H) colorectal cancer. , 2018 .
[34] H. Tilg,et al. The Intestinal Microbiota in Colorectal Cancer. , 2018, Cancer cell.
[35] B. Stockwell,et al. Determination of the Subcellular Localization and Mechanism of Action of Ferrostatins in Suppressing Ferroptosis. , 2018, ACS chemical biology.
[36] Drew M. Pardoll,et al. Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria , 2018, Science.
[37] M. Sawyer,et al. Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Metastatic Colorectal Cancer. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[38] M. Cabana,et al. Lactobacillus reuteri to Treat Infant Colic: A Meta-analysis , 2018, Pediatrics.
[39] R. Banerjee,et al. Chemical Biology of H2S Signaling through Persulfidation. , 2017, Chemical reviews.
[40] Defa Li,et al. Butyrate: A Double-Edged Sword for Health? , 2018, Advances in nutrition.
[41] A. Kimmelman,et al. Metabolic Interactions in the Tumor Microenvironment. , 2017, Trends in cell biology.
[42] Wei Li,et al. YEATS2 links histone acetylation to tumorigenesis of non-small cell lung cancer , 2017, Nature Communications.
[43] F. Shanahan,et al. The oral microbiota in colorectal cancer is distinctive and predictive , 2017, Gut.
[44] J. Gordon,et al. Lactobacillus reuteri induces gut intraepithelial CD4+CD8αα+ T cells , 2017, Science.
[45] Kepeng Wang,et al. Microbiome, inflammation and colorectal cancer. , 2017, Seminars in immunology.
[46] Phillip G. Montgomery,et al. Defining a Cancer Dependency Map , 2017, Cell.
[47] J. M. Landete,et al. Optimization of reuterin production in cheese by Lactobacillus reuteri , 2017, Journal of Food Science and Technology.
[48] C. Capristo,et al. Lactobacillus reuteri DSM 17938 plus vitamin D3 as ancillary treatment in allergic children with asthma. , 2016, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[49] Olivia I. Koues,et al. The Colonic Crypt Protects Stem Cells from Microbiota-Derived Metabolites , 2016, Cell.
[50] B. Győrffy,et al. Iron Uptake via DMT1 Integrates Cell Cycle with JAK-STAT3 Signaling to Promote Colorectal Tumorigenesis. , 2016, Cell metabolism.
[51] Måns Magnusson,et al. MultiQC: summarize analysis results for multiple tools and samples in a single report , 2016, Bioinform..
[52] Ahmedin Jemal,et al. Global patterns and trends in colorectal cancer incidence and mortality , 2016, Gut.
[53] T. Weir,et al. Crosstalk between Microbiota-Derived Short-Chain Fatty Acids and Intestinal Epithelial HIF Augments Tissue Barrier Function. , 2015, Cell host & microbe.
[54] Tong Un Chae,et al. Metabolic engineering of Escherichia coli for the production of 1,3-diaminopropane, a three carbon diamine , 2013, Scientific Reports.
[55] Kyongbum Lee,et al. Prediction and quantification of bioactive microbiota metabolites in the mouse gut , 2014, Nature Communications.
[56] A. Walch,et al. Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice , 2014, Nature Cell Biology.
[57] B. Wilson,et al. Gut Microbial Metabolism Drives Transformation of Msh2-Deficient Colon Epithelial Cells , 2014, Cell.
[58] Wei Shi,et al. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features , 2013, Bioinform..
[59] G. Núñez,et al. Gut microbiota protects against gastrointestinal tumorigenesis caused by epithelial injury. , 2013, Cancer research.
[60] S. Rivella,et al. Intestinal HIF2α promotes tissue-iron accumulation in disorders of iron overload with anemia , 2013, Proceedings of the National Academy of Sciences.
[61] Thomas R. Gingeras,et al. STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..
[62] L. Stronati,et al. Randomised clinical trial: the effectiveness of Lactobacillus reuteri ATCC 55730 rectal enema in children with active distal ulcerative colitis , 2012, Alimentary pharmacology & therapeutics.
[63] B. Borhan,et al. The antimicrobial compound reuterin (3-hydroxypropionaldehyde) induces oxidative stress via interaction with thiol groups. , 2010, Microbiology.
[64] Martin Hartmann,et al. Introducing mothur: Open-Source, Platform-Independent, Community-Supported Software for Describing and Comparing Microbial Communities , 2009, Applied and Environmental Microbiology.
[65] W. R. Wikoff,et al. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites , 2009, Proceedings of the National Academy of Sciences.
[66] J. Rabinowitz,et al. Absolute quantitation of intracellular metabolite concentrations by an isotope ratio-based approach , 2008, Nature Protocols.
[67] Kathleen R. Cho,et al. Mouse model of colonic adenoma-carcinoma progression based on somatic Apc inactivation. , 2007, Cancer research.
[68] P. Shannon,et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.
[69] W. Dobrogosz,et al. Chemical characterization of an antimicrobial substance produced by Lactobacillus reuteri , 1989, Antimicrobial Agents and Chemotherapy.